A. Contu
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Cancer survivorship and care
- HER2/EGFR in Cancer Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 25
- Cancer Treatment and Pharmacology 13
-
- Lung Cancer Treatments and Mutations 8
- Co-authors
- Lucia Del Mastro (6 shared papers)Marco Venturini (4 shared papers)Teodoro Chisesi (11 shared papers)Paolo Bruzzi (4 shared papers)Giovanna Cavazzini (4 shared papers)Gino Santini (10 shared papers)P. Pronzato (4 shared papers)Enrico Aitini (4 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Annals of Oncology (5 papers)Cancer (3 papers)Lung Cancer (3 papers)British Journal of Cancer (2 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
A. Contu
48 papers receiving 766 citations
Peers
Comparison fields: 5 of 85
- Oncology 486
- Pathology and Forensic Medicine 222
- Cancer Research 181
- Pulmonary and Respiratory Medicine 190
- Genetics 60
Countries citing papers authored by A. Contu
This map shows the geographic impact of A. Contu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Contu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Contu more than expected).
Fields of papers citing papers by A. Contu
This network shows the impact of papers produced by A. Contu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Contu. The network helps show where A. Contu may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Contu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 107 | |
| 2 | 2001 | 89 | |
| 3 | 2004 | 52 | |
| 4 | 1999 | 48 | |
| 5 | 1992 | 34 | |
| 6 | 1994 | 31 | |
| 7 | 2012 | 28 | |
| 8 | 2005 | 28 | |
| 9 | 2005 | 24 | |
| 10 | 2001 | 24 | |
| 11 | 1991 | 22 | |
| 12 | Rapsody: randomized prospective phase II trial of two schedules of sorafenib daily and interferon-α 2A (IFN) in metastatic renal cell carcinoma (MRCC). GOIRC study 0681 | 2007 | 21 |
| 13 | 2002 | 19 | |
| 14 | 2004 | 19 | |
| 15 | 1995 | 18 | |
| 16 | 2009 | 17 | |
| 17 | 2003 | 17 | |
| 18 | 2009 | 17 | |
| 19 | 2007 | 15 | |
| 20 | 1998 | 14 |
About A. Contu
A. Contu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Molecular Biology, having authored 51 papers that have together received 802 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), Lymphoma Diagnosis and Treatment (11 papers), Breast Cancer Treatment Studies (8 papers), Lung Cancer Treatments and Mutations (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), BRCA gene mutations in cancer (5 papers), Cancer Genomics and Diagnostics (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Oncology (486 citations), Pathology and Forensic Medicine (222 citations), Cancer Research (181 citations), Pulmonary and Respiratory Medicine (190 citations) and Genetics (60 citations). A. Contu has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Lucia Del Mastro, Marco Venturini, Teodoro Chisesi, Paolo Bruzzi, Giovanna Cavazzini, Gino Santini, P. Pronzato, Enrico Aitini, Luigi Salvagno and P Coser. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, Lung Cancer and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.